Study guide

5.4 Physiological Effects of Substance Use Across Body Systems

National Certified Addiction Counselor NCAC

Track your progress as you read

Finished sections get a check mark.

1 Introduction to NCAC & Addiction Counseling

0.1 NCAC Exam Structure, Eligibility, and Scoring 0.2 The 12 Core Functions & TAP 21 Addiction Counseling Competencies 0.3 Study Strategy and Exam Navigation for Addiction Counselors

2 Chapter 1: Screening, Intake, and Initial Orientation

1.1 Screening Instruments, Risk Stratification, and SBIRT Protocols 1.2 The Intake Process: Clinical and Administrative Data Collection 1.3 Client Orientation, Rights, Informed Consent, and Program Expectations 1.4 Mandated, Court-Referred, and Justice-Involved Clients

3 Chapter 2: Initial Case Management and Referral Foundations

2.1 Stages of Change (Transtheoretical Model) and Initial Engagement 2.2 Referral Coordination, Community Resources, and Interdisciplinary Linkage 2.3 Harm Reduction, Overdose Prevention, and Low-Threshold Engagement

4 Chapter 3: Biopsychosocial Assessment & Diagnostic Foundations

3.1 Comprehensive Biopsychosocial Assessment & The Addiction Severity Index (ASI) 3.2 DSM-5-TR Substance Use Disorders: Criteria, Specifiers, and Neurobiology of Addiction 3.3 Behavioral and Process Addictions: Assessment and Clinical Features 3.4 Models and Theories of Addiction Etiology

5 Chapter 4: Co-Occurring Disorders & Risk Assessment

4.1 Co-Occurring Mental Health Disorders & Differential Diagnosis 4.2 Suicide Risk Assessment, Self-Harm, and Crisis Safety Planning 4.3 Trauma-Informed Assessment, PTSD, and Adverse Childhood Experiences (ACEs)

6 Chapter 5: Medical, Toxicology, and Special Population Considerations

5.1 Medical Evaluation, Toxicology Screening, and Infectious Disease Risks 5.2 Cultural, Developmental, and Special Population Assessment Adaptations 5.3 Psychopharmacology of the Major Drug Classes 5.4 Physiological Effects of Substance Use Across Body Systems

7 Chapter 6: The ASAM Criteria & Level of Care Placement

6.1 The ASAM Criteria: The Six Multidimensional Assessment Dimensions 6.2 ASAM Continuum of Care: Levels 0.5 Through 4.0 6.3 Placement Matching, Continued Service, Transfer, and Discharge Criteria

8 Chapter 7: Individualized Treatment Planning & Pharmacotherapy

7.1 Developing Measurable, Individualized Treatment Plans (SMART Objectives) 7.2 Medications for Addiction Treatment (MAT/MOUD) and Pharmacotherapies 7.3 Monitoring Clinical Progress, Plan Review, and Interdisciplinary Care

9 Chapter 8: Case Management, Relapse Prevention & Continuing Care

8.1 Case Management Models, Advocacy, and Resource Coordination 8.2 Relapse Dynamics, Warning Signs, and Relapse Prevention Models 8.3 Continuing Care, Recovery Capital, and Peer Support Systems 8.4 Clinical Documentation, Progress Notes, and the Golden Thread 8.5 Outcome Measurement, Program Evaluation, and Evidence-Based Practice

10 Chapter 9: Core Counseling Modalities & Individual Skills

9.1 Motivational Interviewing: Spirit, Principles, OARS, and Change Talk 9.2 Cognitive Behavioral Therapy (CBT) & REBT in Addiction Treatment 9.3 Additional Evidence-Based Approaches: SFBT, Contingency Management, and Mindfulness 9.4 Mutual-Help Programs, Twelve-Step Facilitation, and Recovery Support

11 Chapter 10: Group Dynamics & Family Systems

10.1 Group Counseling Dynamics, Types of Groups, and Yalom's Therapeutic Factors 10.2 Group Leadership Skills, Managing Challenging Behaviors, and Developmental Stages 10.3 Family Systems Theory, Roles, Codependency, and Family Interventions

12 Chapter 11: Crisis Intervention & Psychoeducation

11.1 Crisis Intervention Models, De-escalation Techniques, and Overdose Response 11.2 Psychoeducation, Health Literacy, and Client Self-Advocacy

13 Chapter 12: Legal Standards, Confidentiality & 42 CFR Part 2

12.1 Federal Confidentiality Regulations: 42 CFR Part 2 and HIPAA Integration 12.2 Duty to Warn / Protect (Tarasoff) and Mandated Reporting Laws 12.3 Legal Issues, Subpoenas, Court Mandates, and Clinical Record Retention 12.4 Confidentiality with Minors, Groups, Families, and Collaterals

14 Chapter 13: NAADAC Ethics, Cultural Humility & Supervision

13.1 The NAADAC Code of Ethics: Core Principles, Boundaries, and Dual Relationships 13.2 Cultural Humility, Implicit Bias, and Culturally Responsive Care 13.3 Clinical Supervision, Professional Impairment, Compassion Fatigue, and Self-Care 13.4 Technology in Practice: Telehealth, E-Supervision, AI, and Social Media 13.5 Professional Development, Credentialing, and Scope of Practice

5.4 Physiological Effects of Substance Use Across Body Systems

Key Takeaways Explain This Topic AI

Wernicke encephalopathy is a thiamine-deficiency emergency presenting with confusion, ataxia, and ophthalmoplegia; untreated it progresses to Korsakoff syndrome, characterized by anterograde amnesia and confabulation that is largely irreversible.

Alcoholic liver disease progresses from reversible fatty liver through alcoholic hepatitis to cirrhosis, and portal hypertension from cirrhosis produces esophageal varices that can bleed catastrophically.

Stimulants cause cardiovascular emergencies at any dose and in young clients, including myocardial infarction, stroke, arrhythmia, hyperthermia, and rhabdomyolysis, so chest pain in a stimulant user is never dismissed as anxiety.

Fetal alcohol spectrum disorders are the leading preventable cause of intellectual disability and no safe amount or trimester of alcohol exposure has been established, whereas neonatal opioid withdrawal syndrome is treatable and is not a reason to discontinue methadone or buprenorphine in pregnancy.

Cognitive impairment from chronic substance use directly affects treatment: clients in early abstinence often cannot retain complex verbal information, which requires written materials, repetition, and re-teaching rather than a conclusion that the client is resistant.

Last updated: August 2026

5.4 Physiological Effects of Substance Use Across Body Systems

Counselors do not diagnose or treat medical conditions, but they are frequently the professional who sees the client most often. Recognizing the physical consequences of substance use is what turns a routine session into a timely referral — and on the NCC AP examination, items in this area typically ask what the counselor should notice and do , not what medication should be prescribed.

Section 5.1 covers the medical evaluation, laboratory biomarkers, toxicology testing, and infectious disease screening. This section covers the organ-system consequences themselves.

1. Hepatic and Gastrointestinal

Alcoholic liver disease progresses in three recognized stages:

Hepatic steatosis (fatty liver) — present in most heavy drinkers, usually asymptomatic, and reversible with abstinence . This is the single most useful fact to give a client who believes the damage is already done.

Alcoholic hepatitis — inflammation with jaundice, right upper quadrant pain, fever, and elevated transaminases. Partially reversible; severe cases carry high mortality.

Cirrhosis — irreversible fibrosis and nodular regeneration. Abstinence still improves survival substantially even at this stage.

Complications of cirrhosis to recognize:

Portal hypertension and esophageal varices. Ruptured varices produce hematemesis (vomiting blood) or melena (black tarry stool) and are a medical emergency .

Ascites — abdominal fluid accumulation with visible distension.

Hepatic encephalopathy — confusion, sleep-wake reversal, and asterixis (a flapping tremor) caused by ammonia accumulation. It is easily mistaken for intoxication or for a psychiatric decompensation; the differentiating clue is the flapping tremor and the fetor.

Jaundice, spider angiomata, palmar erythema, easy bruising from impaired synthetic function.

Other GI effects: alcohol-induced gastritis and ulcer disease; acute and chronic pancreatitis (severe epigastric pain radiating to the back, a leading alcohol-related emergency); Mallory-Weiss tears from repeated vomiting; opioid-induced constipation , which is a persistent, non-tolerating side effect and a frequent reason clients stop taking prescribed MOUD; cannabinoid hyperemesis syndrome , presenting as cyclic vomiting relieved by hot bathing in a heavy long-term cannabis user.

2. Neurological

Condition Substance Presentation Counselor Action

Wernicke encephalopathy Alcohol (thiamine deficiency) Classic triad of confusion, ataxia, and ophthalmoplegia or nystagmus — often incomplete, so any one of the three in a malnourished drinker counts Medical emergency. Thiamine must be given before glucose; giving carbohydrate first can precipitate or worsen the encephalopathy

Korsakoff syndrome Untreated Wernicke Anterograde amnesia with confabulation , relatively preserved older memory and intellect Largely irreversible; supported living and memory aids; not "lying" when the client confabulates

Withdrawal seizures Alcohol, benzodiazepines, barbiturates Generalized tonic-clonic, typically 12 to 48 hours after last drink Medical withdrawal management; never manage in an unmonitored setting

Delirium tremens Alcohol Onset typically 48 to 96 hours: gross tremor, disorientation, hallucinations, autonomic instability, fever Emergency ; historically high mortality untreated

Peripheral neuropathy Alcohol; nitrous oxide (B12 inactivation) Distal burning, numbness, weakness, gait instability Medical referral; falls risk

Cerebellar degeneration Chronic alcohol Wide-based gait, limb ataxia persisting into abstinence Physical therapy referral; safety planning

Toxic leukoencephalopathy Inhalants; occasionally inhaled heroin Progressive cognitive and motor decline Neurology referral; poor prognosis with continued use

Stroke Stimulants, especially cocaine and methamphetamine Sudden focal deficit, severe headache Call emergency services; time-critical

3. Cardiovascular and Pulmonary

Stimulants are the class most likely to produce an acute cardiovascular emergency, and they do so in young people with no prior cardiac history:

Myocardial infarction from coronary vasoconstriction and thrombosis — cocaine-associated chest pain must be medically evaluated, never reassured away as anxiety or a panic attack.

Arrhythmias, aortic dissection, hypertensive crisis.

Hyperthermia and rhabdomyolysis — muscle breakdown producing dark urine and acute kidney injury, especially with methamphetamine and MDMA in hot environments.

Methamphetamine-associated cardiomyopathy with heart failure in people in their thirties.

Alcohol produces dilated cardiomyopathy, atrial fibrillation ("holiday heart"), and hypertension. Opioids are cardiovascularly benign but lethal through respiratory depression; methadone prolongs the QT interval , which is why QT monitoring is part of OTP care.

Pulmonary: tobacco and cannabis smoking produce chronic bronchitis and COPD; crack cocaine produces "crack lung" and pneumothorax; injection drug use produces septic pulmonary emboli; inhalants can cause sudden sniffing death syndrome through cardiac sensitization to catecholamines, which can occur on a first exposure.

4. Endocrine, Renal, and Musculoskeletal

Opioid-induced endocrinopathy: suppressed testosterone and estrogen causing low libido, fatigue, amenorrhea, infertility, and osteoporosis. Clients often attribute these to "still not feeling right" in recovery; they are treatable and warrant medical referral.

Alcohol: hypoglycemia, ketoacidosis, osteoporosis, testicular atrophy and gynecomastia in advanced liver disease.

Anabolic steroids: suppressed endogenous testosterone, testicular atrophy, gynecomastia, acne, virilization in women, hepatic and lipid effects, and severe withdrawal depression with suicide risk .

Renal: rhabdomyolysis-induced acute kidney injury; analgesic nephropathy; hypertension-related chronic kidney disease. This matters directly for pharmacotherapy — acamprosate is contraindicated in severe renal impairment , whereas it is the safer choice in liver disease.

5. Pregnancy and Neonatal Effects

Exposure Principal Effects Clinical Guidance

Alcohol Fetal alcohol spectrum disorders (FASD) , including fetal alcohol syndrome: growth restriction, characteristic facial features (smooth philtrum, thin vermilion border, short palpebral fissures), and central nervous system impairment The leading preventable cause of intellectual disability. No safe amount, no safe trimester, no safe type of alcohol has been established.

Opioids Neonatal opioid withdrawal syndrome (NOWS) : irritability, high-pitched cry, poor feeding, tremor, hypertonia, diarrhea Treatable and time-limited. NOWS is not a reason to stop methadone or buprenorphine. Untreated OUD in pregnancy carries far higher risk to both patient and fetus, and abrupt withdrawal risks fetal distress and relapse-related overdose.

Tobacco Low birth weight, preterm birth, placental complications, elevated SIDS risk Cessation support is indicated at any point in pregnancy

Stimulants Placental abruption, preterm birth, growth restriction, hypertensive complications The 1980s "crack baby" narrative overstated long-term neurodevelopmental effects and drove punitive policy; counsel from current evidence

Cannabis Lower birth weight; neurodevelopmental effects under study Advise abstinence in pregnancy and lactation

Important

Pregnancy changes the counselor's stance, not the client's rights. Punitive reporting policies deter pregnant people from seeking care, which worsens outcomes. Know your state's specific reporting requirements — they vary widely — disclose them at intake under NAADAC Standard I-3, and prioritize engagement and medical linkage. Pregnant people are a federally designated priority population for admission to publicly funded SUD treatment.

6. Cognition, and What It Means for Your Session

Chronic use produces measurable deficits in working memory, sustained attention, processing speed, and executive function — the exact capacities a treatment program asks a client to use. These deficits are typically most severe in the first weeks of abstinence and improve substantially over months, though the trajectory varies by substance, duration, and age.

The clinical error to avoid is interpreting cognitive impairment as motivation. A client who cannot repeat back the relapse prevention plan you spent 40 minutes constructing may not be resistant, minimizing, or "not ready" — they may be unable to encode it right now.

Concrete adjustments:

Give information in short segments and check comprehension with teach-back.

Provide written summaries of every plan, appointment, and instruction.

Repeat key content across multiple sessions rather than covering it once.

Delay complex cognitive work such as detailed functional analysis until acute impairment resolves.

Use external memory supports : phone alarms, appointment cards, pillboxes, a single notebook.

Reassess rather than concluding permanent impairment — reevaluate after 30 to 90 days of abstinence.

Document the impairment and the accommodations; they may also support a level-of-care argument under ASAM Dimension 3.